| Application number | Title of the application | Filing Date | Status |
|---|
| 90/013003 | Method of Making and decoding of Array Sensors with Microspheres | Sep 19, 2013 | Issued |
Array
(
[id] => 12085454
[patent_doc_number] => RE046631
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2017-12-12
[patent_title] => 'Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4'
[patent_app_type] => reissue
[patent_app_number] => 13/896384
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 30912
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896384
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896384 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | May 16, 2013 | Issued |
Array
(
[id] => 13634439
[patent_doc_number] => RE046641
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2017-12-19
[patent_title] => Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
[patent_app_type] => reissue
[patent_app_number] => 13/896388
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 25423
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896388 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | May 16, 2013 | Issued |
Array
(
[id] => 11766451
[patent_doc_number] => RE046042
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2016-06-28
[patent_title] => 'Development of dengue virus vaccine components'
[patent_app_type] => reissue
[patent_app_number] => 13/895908
[patent_app_country] => US
[patent_app_date] => 2013-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11976
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895908
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/895908 | Development of dengue virus vaccine components | May 15, 2013 | Issued |
| 90/012860 | REACTION MIXTURES FOR DETECTION OF TARGET NUCLEIC ACIDS | May 5, 2013 | Pending |
| 96/000021 | PHARMACEUTICAL COMPOSITIONS FOR FREEZE DRYING | Apr 29, 2013 | Pending |
| 90/012851 | ANTI-TNFA ANTIBODIES AND ASSAYS EMPLOYING ANTI-TNFA ANTIBODIES | Apr 28, 2013 | Issued |
| 90/012806 | METHOD FOR THE DETECTION OF CLONAL POPULATIONS OF TRANSFORMED CELLS IN A GENOMICALLY HETEROGENEOUS CELLULAR SAMPLE | Mar 17, 2013 | Issued |
| 90/012801 | INTRON SEQUENCE ANALYSIS METHOD FOR DETECTION OF ADJACENT AND REMOTE LOCUS ALLELES AS HAPLOTYPES | Feb 28, 2013 | Issued |
Array
(
[id] => 12443703
[patent_doc_number] => RE046877
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-05-29
[patent_title] => Altered antibodies and their preparation
[patent_app_type] => reissue
[patent_app_number] => 13/683113
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 8601
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683113
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/683113 | Altered antibodies and their preparation | Nov 20, 2012 | Issued |
| 90/012704 | METHODS OF CLEAVING DNA WITH RATIONALLY-DESIGNED MEGANUCLEASES | Oct 14, 2012 | Issued |
| 90/020027 | RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY | Oct 4, 2012 | Issued |
| 95/002224 | METHOD AND COMPOSITION FOR AN EARLY VACCINE TO PROTECT AGAINST BOTH COMMON INFECTIOUS DISEASES AND CHRONIC IMMUNE MEDIATED DISORDERS OR THEIR SEQUELAE | Sep 12, 2012 | Issued |
| 90/012527 | Process and Materials for Production of Glucosamine and N-Acetylglucosamine | Sep 12, 2012 | Issued |
| 95/002208 | METHOD AND COMPOSITION FOR AN EARLY VACCINE TO PROTECT AGAINST BOTH COMMON INFECTIOUS DISEASES AND CHRONIC IMMUNE MEDIATED DISORDERS OR THEIR SEQUELAE | Sep 12, 2012 | Issued |
| 95/002182 | METHOD AND COMPOSITION FOR AN EARLY VACCINE TO PROTECT AGAINST BOTH COMMON INFECTIOUS DISEASES AND CHRONIC IMMUNE MEDIATED DISORDERS OR THEIR SEQUELAE | Sep 11, 2012 | Issued |
| 95/002065 | Inter Partes Reexamination of U.S. Patent No. 8,153,399 entitled: Methods and compositions for inactivating glutamine synthetase gene expression | Aug 2, 2012 | Issued |
| 90/012377 | Antibodies to Troponin I and Methods of Use Thereof | Jul 16, 2012 | Issued |
| 90/012335 | OVEREXPRESSION OF MAMMALIAN AND VIRAL PROTEINS | Jun 21, 2012 | Issued |
| 90/012334 | HIGH LEVEL EXPRESSION OF PROTEINS | May 31, 2012 | Issued |
